Trial intelligence / Profile preview

Petrolatum effect on skin innate immune responses

NCT02338076Completed

Sponsor
The Rockefeller University
Start
Jun 2013
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of petrolatum jelly in skin infection (SSTI), sponsored by The Rockefeller University. Primary endpoints: Expression Levels of Antimicrobial Peptides at 3 days and Measurement of Innate Immune Genes (IL6, IL8, and IL1B) at 3 days. Started Jun 2013; status: completed.

02

Drugs

petrolatum jelly
03

Conditions

skin infection (SSTI)

Beyond the preview

Go deeper on NCT02338076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02338076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call